123 related articles for article (PubMed ID: 37080857)
61. Prospective Longitudinal Assessment of Quality of Life and Activities of Daily Living as Patient-Reported Outcome Measures in Recurrent/Progressive Glioma Treated with High-dose Salvage Re-irradiation.
Maitre P; Gupta T; Maitre M; Goda J; Krishnatry R; Chatterjee A; Sridhar E; Sahay A; Mokal S; Moiyadi A; Shetty P; Patil V; Jalali R
Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):e155-e165. PubMed ID: 32917486
[TBL] [Abstract][Full Text] [Related]
62. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
[TBL] [Abstract][Full Text] [Related]
63. Health-related quality of life in long-term survivors with Grade II gliomas: the contribution of disease recurrence and Karnofsky Performance Status.
Okita Y; Narita Y; Miyahara R; Miyakita Y; Ohno M; Shibui S
Jpn J Clin Oncol; 2015 Oct; 45(10):906-13. PubMed ID: 26232448
[TBL] [Abstract][Full Text] [Related]
64. General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition.
Arraras JI; Nolte S; Liegl G; Rose M; Manterola A; Illarramendi JJ; Zarandona U; Rico M; Teiejria L; Asin G; Hernandez I; Barrado M; Vera R; Efficace F; Giesinger JM;
Health Qual Life Outcomes; 2021 Aug; 19(1):208. PubMed ID: 34461909
[TBL] [Abstract][Full Text] [Related]
65. The association between cognitive functioning and health-related quality of life in low-grade glioma patients.
Boele FW; Zant M; Heine EC; Aaronson NK; Taphoorn MJ; Reijneveld JC; Postma TJ; Heimans JJ; Klein M
Neurooncol Pract; 2014 Jun; 1(2):40-46. PubMed ID: 26034615
[TBL] [Abstract][Full Text] [Related]
66. Proton therapy re-irradiation preserves health-related quality of life in large recurrent glioblastoma.
Scartoni D; Amelio D; Palumbo P; Giacomelli I; Amichetti M
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1615-1622. PubMed ID: 32200460
[TBL] [Abstract][Full Text] [Related]
67. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
[TBL] [Abstract][Full Text] [Related]
68. Self-perceived cognitive functioning and quality of life among cancer survivors: results from the PROFILES registry.
Oerlemans S; Schagen SB; van den Hurk CJ; Husson O; Schoormans D; van de Poll-Franse LV
J Cancer Surviv; 2022 Apr; 16(2):303-313. PubMed ID: 33728574
[TBL] [Abstract][Full Text] [Related]
69. Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.
Lenz HJ; Argiles G; Yoshino T; Lonardi S; Falcone A; Limón ML; Sobrero A; Hastedt C; Peil B; Voss F; Griebsch I; Van Cutsem E
Clin Colorectal Cancer; 2019 Dec; 18(4):269-279.e5. PubMed ID: 31628043
[TBL] [Abstract][Full Text] [Related]
70. Content validation of the EORTC QLQ-C15-PAL with advanced cancer patients and health care professionals from palliative care services in Chile.
Rojas-Concha L; Hansen MB; Petersen MA; Groenvold M
BMC Palliat Care; 2020 Jun; 19(1):81. PubMed ID: 32517678
[TBL] [Abstract][Full Text] [Related]
71. Are neurologic symptoms associated with worse QoL in non-CNS cancer patients?
Cacho-Díaz B; González-González E; Mauricio Bonilla-Navarrete A; Texcocano-Becerra J; Oñate-Ocaña LF
J Clin Neurosci; 2023 May; 111():39-45. PubMed ID: 36934658
[TBL] [Abstract][Full Text] [Related]
72. The validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China.
Cheng JX; Liu BL; Zhang X; Zhang YQ; Lin W; Wang R; Zhang YQ; Zhang HY; Xie L; Huo JL
BMC Med Res Methodol; 2011 Apr; 11():56. PubMed ID: 21513533
[TBL] [Abstract][Full Text] [Related]
73. Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy.
Hong F; Bosco JL; Bush N; Berry DL
BMC Cancer; 2013 Mar; 13():165. PubMed ID: 23537330
[TBL] [Abstract][Full Text] [Related]
74. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
[TBL] [Abstract][Full Text] [Related]
75. The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis.
Heinzel A; Mottaghy FM; Filss C; Stoffels G; Lohmann P; Friedrich M; Shah NJ; Caspers S; Lucas CW; Ruge MI; Galldiks N; Fink GR; Langen KJ; Kocher M
J Neurooncol; 2023 Feb; 161(3):643-654. PubMed ID: 36750534
[TBL] [Abstract][Full Text] [Related]
76. Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.
Mendez LC; Raman S; Wan BA; da Silva JLP; Moraes FY; Lima KMLB; Silva MF; Diz MDPE; Chow E; Marta GN
Ann Palliat Med; 2017 Aug; 6(Suppl 1):S65-S70. PubMed ID: 28595442
[TBL] [Abstract][Full Text] [Related]
77. Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial.
Kepka L; Tyc-Szczepaniak D; Osowiecka K; Sprawka A; Trąbska-Kluch B; Czeremszynska B
Clin Transl Oncol; 2018 Feb; 20(2):150-159. PubMed ID: 28616720
[TBL] [Abstract][Full Text] [Related]
78. Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma.
Osoba D; Aaronson NK; Muller M; Sneeuw K; Hsu MA; Yung WK; Brada M; Newlands E
J Neurooncol; 1997 Sep; 34(3):263-78. PubMed ID: 9258818
[TBL] [Abstract][Full Text] [Related]
79. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
[TBL] [Abstract][Full Text] [Related]
80. Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study.
Machingura A; Taye M; Musoro J; Ringash J; Pe M; Coens C; Martinelli F; Tu D; Basch E; Brandberg Y; Grønvold M; Eggermont A; Cardoso F; Van Meerbeeck J; van der Graaf WTA; Taphoorn M; Reijneveld JC; Soffietti R; Sloan J; Velikova G; Flechtner H; Bottomley A;
Eur J Cancer; 2022 Jul; 170():1-9. PubMed ID: 35569438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
